Loading clinical trials...
Loading clinical trials...
LARCID: Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea
Conditions
Interventions
Octreotide Long Acting Release
Standard Treatment
Locations
11
Brazil
Biocâncer
Belo Horizonte, Brazil
CEPON-Centro de Pesquisas Oncologicas
Florianópolis, Brazil
Hospital Sao Lucas- Faculdade de Medicina da PUCRS
Porto Alegre, Brazil
Clínica AMO
Salvador, Brazil
Nucleo de Oncologia da Bahia
Salvador, Brazil
Faculdade de Medicina do ABC
Santo André, Brazil
Start Date
April 1, 2008
Primary Completion Date
September 1, 2010
Completion Date
September 1, 2010
Last Updated
May 4, 2015
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions